Impaired oxidation of branched-chain amino acids in the medial thalamus of thiamine-deficient rats.
Thiamine, in its diphosphate form, is a required cofactor for enzymes of glucose metabolism and branched-chain alpha-ketoacid dehydrogenase (BCKDH). Although metabolic impairments in glucose metabolism have been found to occur in selectively vulnerable brain regions of the thiamine-deficient (TD) brain, the effects of thiamine deficiency on BCKDH have not been studied. BCKDH activity was assayed radiochemically in brain extracts of vulnerable (medial thalamus; MT) versus non-vulnerable (frontal cortex; FC) brain regions of rats made TD by administration of the central thiamine antagonist, pyrithiamine. A significant regional variation in BCKDH within the TD rat brain was noted, with a higher capacity for branched-chain amino acid oxidation in FC compared to MT: BCKDH activity was significantly reduced in MT of TD rats, resulting in selective accumulation of BCAAs in this brain region. Leucine concentrations were elevated over fivefold in the MT of symptomatic TD rats, compared with pair-fed control (PFC) rats. Impaired branched-chain ketoacid metabolism in rats may contribute to the neuronal dysfunction and ultimate thalamic neuronal cell death observed in thiamine deficiency.
Navarro
Darren
D
Neuroscience Research Unit, CHUM (Saint-Luc Hospital), University of Montreal, 1058, Saint-Denis Street, Montreal, QC, H2X 3J4, Canada.
Zwingmann
Claudia
C
Butterworth
Roger F
RF
D042942:3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) / Q000378:metabolism*; D000597:Amino Acids, Branched-Chain / Q000378:metabolism*; D000704:Analysis of Variance; D000818:Animals; D003067:Coenzymes / Q000378:metabolism; D005625:Frontal Lobe / Q000378:metabolism; D008297:Male; D010084:Oxidation-Reduction; D051381:Rats; D017207:Rats, Sprague-Dawley; D013788:Thalamus / Q000378:metabolism*; D013832:Thiamine Deficiency / Q000378:metabolism*
D000597:Amino Acids, Branched-Chain; D003067:Coenzymes; D042942:3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)
Curr Opin Clin Nutr Metab Care. 2001 Sep;4(5):419-23
11568504
Dev Neurosci. 1993;15(3-5):343-50
7805588
J Nutr. 2006 Jan;136(1 Suppl):243S-9S
16365091
Biochem Biophys Res Commun. 1982 Aug 31;107(4):1497-503
6291534
J Cereb Blood Flow Metab. 2003 Jun;23(6):756-71
12796724
J Neurochem. 1998 Aug;71(2):863-74
9681479
J Histochem Cytochem. 1997 May;45(5):685-94
9154155
J Neurochem. 1989 Apr;52(4):1079-84
2564421
Arch Biochem Biophys. 1984 May 15;231(1):48-57
6721501
Arch Neurol. 1981 Jun;38(6):350-4
7236062
J Lab Clin Med. 1993 Jun;121(6):779-84
8505589
J Nutr. 1996 Jul;126(7):1791-8
8683340
Physiol Rev. 1983 Oct;63(4):1481-535
6361813
Can J Physiol Pharmacol. 1985 Oct;63(10):1234-8
4075248
Am J Physiol. 1986 May;250(5 Pt 1):E599-604
3706523
J Neurochem. 1994 Mar;62(3):1192-202
7906717
Anal Biochem. 1993 Aug 15;213(1):23-8
8238877
Dev Neurosci. 1996;18(5-6):420-5
8940614
Methods Enzymol. 1988;166:189-201
3071701
Neurochem Res. 1997 Sep;22(9):1159-64
9251107
J Neurochem. 1996 May;66(5):2136-45
8780046
Pediatrics. 2002 Jun;109(6):999-1008
12042535
Glia. 1997 Sep;21(1):92-8
9298851